Sodium Restriction in the Management of Cirrhotic Ascites
Primary Purpose
Ascites
Status
Terminated
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Sodium restriction
Sodium restriction
Sponsored by
About this trial
This is an interventional treatment trial for Ascites focused on measuring cirrhosis, portal hypertension, ascites, sodium restriction
Eligibility Criteria
Inclusion Criteria:
- Cirrhotic patients of any etiology with ascites from portal hypertension diagnosed by paracentesis,
- Age 18-75
- Clinical or radiographic (abdominal CT or ultrasound) estimate of moderate - severe ascites
- Spanish-speaking subjects will be eligible for participation
Exclusion Criteria:
- Active drug or alcohol abuse,
- Active complications of SBP, hepatic encephalopathy, or GI bleed within 2 weeks,
- Hemorrhagic ascites, malignant ascites,
- Creatinine >2 mg/dL or CCl < 30 mL/min,
- K > 5.5 mmol/L,
- Diuretic refractory ascites
- Allergy to or intolerance of either spironolactone or furosemide
- Homelessness, incarceration, inability to follow up in clinic, or comply with diet.
Sites / Locations
- Parkland Memorial Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
1
2
Arm Description
4 gram sodium diet
2 gram sodium diet
Outcomes
Primary Outcome Measures
Control of ascites
Secondary Outcome Measures
Patient acceptance and compliance
Full Information
NCT ID
NCT00548366
First Posted
October 22, 2007
Last Updated
September 10, 2010
Sponsor
University of Texas Southwestern Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00548366
Brief Title
Sodium Restriction in the Management of Cirrhotic Ascites
Official Title
Comparison of Efficacy of 2 Gram Versus 4 Gram Sodium Restriction in the Management of Cirrhotic Ascites
Study Type
Interventional
2. Study Status
Record Verification Date
September 2010
Overall Recruitment Status
Terminated
Why Stopped
Failure to recruit.
Study Start Date
October 2007 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
September 2010 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University of Texas Southwestern Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
To determine the relationship between degree of sodium restriction and dietary compliance with clinical outcome of diuresis of portal hypertensive ascites in cirrhotic patients from a county hospital population.
Primary objective: Demonstrate that, when accompanied by the appropriate diuretic regimen, a No Added Salt diet (4 grams sodium per day) is as effective as a Low Sodium diet (2 grams sodium per day) in the management of cirrhotic ascites.
Detailed Description
Secondary objectives:
Demonstrate that patient acceptance is greater and diuresis faster with a No Added Salt diet compared with a Low Sodium diet
Demonstrate that side-effects of diuretic therapy are the same or less when patients are on a No Added Salt diet
Determine if glomerular filtration rate estimated from the modified diet in renal disease equation differs from that obtained by a 24 hour urinary creatinine in patients with cirrhotic ascites
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ascites
Keywords
cirrhosis, portal hypertension, ascites, sodium restriction
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
4 gram sodium diet
Arm Title
2
Arm Type
Active Comparator
Arm Description
2 gram sodium diet
Intervention Type
Other
Intervention Name(s)
Sodium restriction
Other Intervention Name(s)
No added salt diet
Intervention Description
4 gram sodium diet
Intervention Type
Other
Intervention Name(s)
Sodium restriction
Other Intervention Name(s)
Low sodium diet
Intervention Description
2 gram sodium diet
Primary Outcome Measure Information:
Title
Control of ascites
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Patient acceptance and compliance
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cirrhotic patients of any etiology with ascites from portal hypertension diagnosed by paracentesis,
Age 18-75
Clinical or radiographic (abdominal CT or ultrasound) estimate of moderate - severe ascites
Spanish-speaking subjects will be eligible for participation
Exclusion Criteria:
Active drug or alcohol abuse,
Active complications of SBP, hepatic encephalopathy, or GI bleed within 2 weeks,
Hemorrhagic ascites, malignant ascites,
Creatinine >2 mg/dL or CCl < 30 mL/min,
K > 5.5 mmol/L,
Diuretic refractory ascites
Allergy to or intolerance of either spironolactone or furosemide
Homelessness, incarceration, inability to follow up in clinic, or comply with diet.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jennifer A Cuthbert, M.D.
Organizational Affiliation
UT Southwestern Medical Center at Dallas
Official's Role
Study Director
Facility Information:
Facility Name
Parkland Memorial Hospital
City
Dallas
State/Province
Texas
ZIP/Postal Code
75235
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Sodium Restriction in the Management of Cirrhotic Ascites
We'll reach out to this number within 24 hrs